A Phase II Trial of Erlotinib as Maintenance Treatment After Gemcitabine Plus Platinum-based Chemotherapy in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma-Reference-Cited by-同舟云学术

A Phase II Trial of Erlotinib as Maintenance Treatment After Gemcitabine Plus Platinum-based Chemotherapy in Patients With Recurrent and/or Metastatic Nasopharyngeal Carcinoma

Published:2012-06 Issue:3 Volume:35 Page:255-260
ISSN:0277-3732
Container-title:American Journal of Clinical Oncology
language:en
Short-container-title:

Author:

You Benoit,Le Tourneau Christophe,Chen Eric X.,Wang Lisa,Jarvi Andrea,Bharadwaj Rikki R.,Kamel-Reid Suzanne,Perez-Ordonez Bayardo,Mann Vijay,Siu Lillian L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Oncology

Reference29 articles.

1. Chemotherapy in locally advanced nasopharyngeal carcinoma: an individual patient data meta-analysis of eight randomized trials and 1753 patients.;Baujat;Int J Radiat Oncol Biol Phys,2006

2. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.;Al-Sarraf;J Clin Oncol,1998

3. Nasopharyngeal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.;Chan;Ann Oncol,2009

4. Systemic approach to improving treatment outcome in nasopharyngeal carcinoma: current and future directions.;Ma;Cancer Sci,2008

5. Gemcitabine and cisplatin in advanced nasopharyngeal carcinoma: a pilot study.;Jiang;Cancer Invest,2005

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maintenance treatment with oral anticancer agents after first-line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: a systematic review and meta-analysis;European Archives of Oto-Rhino-Laryngology;2024-08-28

2. Nasopharyngeal carcinoma: current views on the tumor microenvironment's impact on drug resistance and clinical outcomes;Molecular Cancer;2024-01-22

3. Precision drugs for recurrent or metastatic nasopharyngeal carcinoma (Review);Experimental and Therapeutic Medicine;2023-11-03

4. Recurrent/Metastatic Nasopharyngeal Carcinoma Treatment from Present to Future: Where Are We and Where Are We Heading?;Current Treatment Options in Oncology;2023-06-15

5. Efficacy of local therapy to metastatic foci in nasopharyngeal carcinoma: large-cohort strictly-matched retrospective study;Therapeutic Advances in Medical Oncology;2022-01